Kyle Mikson

Stock Analyst at Canaccord Genuity

(0)
# 4915
Out of 5,328 analysts
93
Total ratings
13.46%
Success rate
-29.11%
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
GH Guardant Health
Maintains: Strong Buy
60 65
49.73 30.71% 6 May 1, 2025
ILMN Illumina
Maintains: Hold
115 92
76.99 19.5% 9 Apr 29, 2025
BDSX Biodesix
Maintains: Buy
4 3
0.53 371.7% 3 Apr 29, 2025
AKYA Akoya Biosciences
Maintains: Hold
4 2
1.2 50% 4 Apr 29, 2025
GRAL GRAIL
Initiates Coverage On: Buy
32
32.81 -2.47% 1 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
170 150
138.91 7.98% 3 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.1 172.73% 8 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 15
5.8 158.62% 5 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
180 195
152.68 27.72% 8 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
8.16 120.59% 7 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 7
6.07 15.32% 2 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.3 130.77% 4 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.15 -13.04% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
95 75
47.45 58.06% 9 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 42
19.42 116.27% 3 Oct 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3 5
n/a n/a 3 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
26
n/a n/a 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 2
n/a n/a 4 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
3
n/a n/a 4 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 2
0.49 308.16% 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
50
0.83 5827.71% 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
19
3.46 449.13% 1 Jan 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
150
n/a n/a 1 Jan 29, 2021